Kynurenine

Kynurenine

SCHEMBL288254

Nc1ccccc1C(=O)CC(N)C(=O)O.Nc1ccccc1C(=O)C[C@H](N)C(=O)O

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.64
▸ HIF1A Q16665 1/20 0.64
▸ TDP1 Q9NUW8 1/20 0.64
▸ KYNU Q16719 2/20 0.49
▸ GAA P10253 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ ALPI P09923 1/20 0.47
▸ PKM P14618 1/20 0.47
▸ PTGS1 P23219 1/20 0.47
▸ XIAP P98170 1/20 0.47
▸ SLC7A5 Q01650 1/20 0.47
▸ KMO O15229 3/20 0.45
▸ SLC1A3 P43003 2/20 0.45
▸ SLC1A2 P43004 2/20 0.45
▸ SLC1A1 P43005 2/20 0.45
▸ GRM2 Q14416 1/20 0.45
▸ GRM3 Q14832 1/20 0.45
▸ GRIK1 P39086 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
L-Kynurenine SCHEMBL29415716 1.00 KDM4E (0.64) KDM4EHIF1ATDP1KYNUGAA
Kynurenine SCHEMBL29349989 1.00 KDM4E (0.64) KDM4EHIF1ATDP1KYNUGAA
Kynurenine SCHEMBL20874 1.00 KDM4E (0.64) KDM4EHIF1ATDP1KYNUGAA
L-Kynurenine SCHEMBL29396313 1.00 KDM4E (0.64) KDM4EHIF1ATDP1KYNUGAA
L-Kynurenine SCHEMBL20875 1.00 KDM4E (0.64) KDM4EHIF1ATDP1KYNUGAA
Kynurenine SCHEMBL288988 1.00 KDM4E (0.64) KDM4EHIF1ATDP1KYNUGAA
L-Kynurenine SCHEMBL288989 1.00 KDM4E (0.64) KDM4EHIF1ATDP1KYNUGAA
Kynurenine SCHEMBL2181581 1.00 KDM4E (0.64) KDM4EHIF1ATDP1KYNUGAA
L-Kynurenine SCHEMBL13969610 1.00 KDM4E (0.64) KDM4EHIF1ATDP1KYNUGAA
L-Kynurenine SCHEMBL2368794 0.98 KDM4E (0.62) KDM4EHIF1ATDP1KYNUGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9511378-B2 Collector compositions and methods for making and using same GEORGIA-PACIFIC CHEMICALS LLC (US) 2016-12-06 — — US disclosed
US-20150096925-A1 COLLECTOR COMPOSITIONS AND METHODS FOR MAKING AND USING SAME JPMORGAN CHASE BANK, N.A. 2015-04-09 — — US disclosed
EP-2449488-A1 METHOD FOR NORMALIZATION IN METABOLOMICS ANALYSIS METHODS WITH ENDOGENOUS REFERENCE METABOLITES BIOCRATES Life Sciences AG (AT) 2012-05-09 — — EP disclosed
EP-2427773-A1 METHOD OF DIAGNOSING ASPHYXIA Keller, Matthias (DE) 2012-03-14 — — EP disclosed
WO-2011083304-A1 PRODRUGS OF OPIOIDS AND USES THEREOF SHIRE LLC (US) 2011-07-14 — — WO disclosed
WO-2011000753-A1 METHOD FOR NORMALIZATION IN METABOLOMICS ANALYSIS METHODS WITH ENDOGENOUS REFERENCE METABOLITES BIOCRATES LIFE SCIENCES AG (AT) 2011-01-06 — — WO disclosed
WO-2010128054-A1 METHOD OF DIAGNOSING ASPHYXIA BIOCRATES LIFE SCIENCES AG (AT) 2010-11-11 — — WO disclosed
Send feedback